The archive · Health & Care · Product decision · 2012–2022
Vezeeta: a Cairo doctor-booking bet that grew to 10M patients, then cut staff
Vezeeta let patients search, book and rate doctors like hotels; the Cairo startup grew to 10 million patients in 78 cities before the 2022 market reset.
Vezeeta
What the business is
Vezeeta is a healthcare platform that lets patients search, book and review doctors and clinics across Egypt, Saudi Arabia, Jordan, Lebanon, Nigeria and Kenya, while selling software to more than 30,000 healthcare providers.
How it started
Amir Barsoum launched Vezeeta in Cairo in 2012 with an ambulance-focused idea that TechCrunch described as a sort of Uber for ambulances; the company gradually reversed into mainstream healthcare, building a free platform where patients can see doctors' schedules and ratings before booking (TechCrunch).
What happened
Vezeeta raised a $12M Series C in September 2018 led by Saudi Technology Ventures and another $1M from the IFC, then closed a $40M Series D in February 2020 led by UAE-based Gulf Capital — one of the largest rounds for any tech startup in the Middle East and North Africa at the time — taking total funding to $63M (TechCrunch; Disrupt Africa). It planned telehealth and online pharmacy products and kept expanding: by June 2022 TechCrunch reported 10 million patients across 78 cities, including new markets Nigeria and Kenya, with $73M raised in total.
How it ended up
The company stayed live but met the venture downturn: in late June 2022 Vezeeta laid off about 10% of its roughly 500-person staff, with affected employees citing market conditions; TechCrunch called it the first major Africa and Middle East healthtech player to cut.
Background
Vezeeta, founded by Amir Barsoum in Cairo in 2012, began as an ambulance-booking idea and became a patient-facing healthcare marketplace: users search, book and rate doctors the way they rate hotels, and more than 30,000 providers use its SaaS to manage bookings (TechCrunch).
The model attracted Gulf capital: Saudi Technology Ventures led a $12M Series C in September 2018, and UAE-based Gulf Capital led a $40M Series D in February 2020 that TechCrunch called one of the largest rounds for any tech startup in the Middle East and North Africa at the time, taking Vezeeta to $63M raised (TechCrunch; Disrupt Africa).
Expansion followed the money: by 2020 the platform ran in 50 cities across Egypt, Saudi Arabia, Jordan and Lebanon with 4 million annual appointments, and by June 2022 TechCrunch reported 10 million patients across 78 cities, including new additions Nigeria and Kenya, on $73M total funding.
The boom did not protect it: in late June 2022 Vezeeta laid off about 10% of its roughly 500-person staff, which TechCrunch described as the first major Africa and Middle East healthtech company to cut in the downturn.
What has to be true
- Ratings gave patients the power that providers had held: a public score gave a clinic a reason to improve service rather than rely on word of mouth.
- The marketplace was also a SaaS business: 30,000+ providers paid for the booking and practice software behind the consumer app.
- Gulf capital was the accelerant: Gulf Capital and Saudi Technology Ventures funded expansion across Saudi Arabia, Jordan, Lebanon and later Nigeria and Kenya.
- The 2022 reset showed the limit: even a company growing from 4 million to 10 million patients could not avoid cutting about 10% of staff when venture funding tightened.
What can be applied
Patient ratings and booking power can force fragmented providers to compete, but boom-funded expansion met the 2022 reset: Vezeeta cut a tenth of staff weeks after being called a regional winner.
Aftermath
As of 2022-06-28 Vezeeta was still live across Egypt, Saudi Arabia, Jordan, Lebanon, Nigeria and Kenya, but had just laid off about 10% of roughly 500 staff in what TechCrunch called the first major Africa and Middle East healthtech cut of the downturn. It had raised about $73M total, grown from 4 million patients in 50 cities to 10 million in 78, and moved beyond consultations into pharmacy and diagnostics; affected employees cited market conditions.
Sources
- Middle East healthcare platform Vezeeta raises $40M Series D led by Gulf Capital
- Egyptian healthtech startup Vezeeta cuts 10% of staff
- Egyptian e-health startup Vezeeta raises $40m Series D funding round
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card